• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

    3/25/25 7:00:00 AM ET
    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Medical/Dental Instruments
    Health Care
    Major Chemicals
    Industrials
    Get the next $AEMD alert in real time by email

    MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com.

    For updates, follow us on Twitter.

    Day 1

    March 26, 2025

    11:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    11:20

    Introduction

    11:25 - 11:55

    Photronics (NASDAQ:PLAB)

    Keynote speaker: Ted Moreau, Vice President IR

    12:00 – 12:30

    AtlasClear Holdings, Inc. (NASDAQ:ATCH)

    Keynote speakers: Craig Ridenhour, President & John Schaible, Chairman and CEO

    12:35 – 1:05

    Bioxytran, Inc. (OTCQB:BIXT) 

    Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

    2:05 – 2:15

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO

    2:20 – 2:50

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest – CEO

    2:55 – 3:05

    RUA Gold, Inc. (OTCQB:NZAUF) (TSXV:RUA)

    Keynote speaker: Robert Eckford, CEO

    3:10 - 3:20

    HydroGraph Clean Power Inc. (OTCQB:HGRAF) (CSE:HG)

    Keynote speaker: Kjirstin Breure, President and CEO

    3:25 - 3:35

    Aethlon Medical, Inc. (NASDAQ:AEMD)

    Keynote speakers: Jim Frakes, CEO and CFO

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    Day 2

    March 27, 2025

    9:15

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    9:40 – 10:10

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    10:15 – 10:45

    Peloton Minerals Corp. (OTCQB:PMCCF) (CSE:PMC)

    Keynote speaker: Edward L. Ellwood, President, CEO & Director

    11:25 – 11:55

    Ideal Power, Inc. (NASDAQ:IPWR)

    Keynote speakers: Dan Brdar: President and CEO, & Tim Burns: CFO

    12:35 – 1:05

    NCS Multistage Holdings, Inc. (NASDAQ:NCSM)

    Keynote speaker: Ryan Hummer, CEO & Director

    1:45 - 2:15

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    2:20 – 2:50

    Vivani Medical, Inc. (NASDAQ:VANI)

    Keynote speaker: Adam Mendelsohn PHD, CEO

    2:55 – 3:05

    Energy Finders, Inc. (OTC:EGYF)

    Keynote Speaker: Keith Pivonski, VP

    3:10 - 3:20

    Brenmiller Energy, Ltd. (NASDAQ:BNRG)

    Keynote speaker: Nir Brenmiller, COO

    3:25 - 3:35

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    3:40 – 3:50

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com.

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: Conference@EmergingGrowth.com



    Primary Logo

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $ASPI
    $ATCH
    $BNRG

    CompanyDatePrice TargetRatingAnalyst
    Photronics Inc.
    $PLAB
    3/20/2026$46.00Buy
    Lake Street
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Aethlon Medical Inc.
    $AEMD
    7/7/2025$1.50Neutral
    H.C. Wainwright
    Photronics Inc.
    $PLAB
    6/11/2025$32.00Buy
    Craig Hallum
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    More analyst ratings

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Photronics with a new price target

    Lake Street initiated coverage of Photronics with a rating of Buy and set a new price target of $46.00

    3/20/26 8:36:50 AM ET
    $PLAB
    Semiconductors
    Technology

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weatherford Announces Second Quarter 2026 Results

    Second quarter revenue of $1,105 million decreased 4% sequentially  Second quarter operating income of $107 million decreased 13% sequentiallySecond quarter net income of $39 million decreased 64% sequentially; net income margin of 3.5%Second quarter adjusted EBITDA* of $223 million, decreased 4% sequentially; adjusted EBITDA margin* of 20.2% decreased 4 basis points sequentiallySecond quarter cash provided by operating activities of $175 million and adjusted free cash flow* of $139 millionShareholder return of $36 million for the quarter, which included dividend payments of $20 million and share repurchases of $16 millionAnnounced the acquisition of NCS Multistage (NASDAQ:NCSM) in a stock-a

    7/21/26 4:30:00 PM ET
    $WFRD
    $NCSM
    Oil and Gas Field Machinery
    Consumer Discretionary
    Oilfield Services/Equipment
    Energy

    ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology

    DALLAS, July 21, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("we," "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has signed a research agreement with the Texas A&M Engineering Experiment Station (TEES) to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), a critical feedstock in the existing nuclear fuel enrichment supply chain. This agreement reflects the growing momentum across Texas' nuclear industry and highlights the value of collaboratio

    7/21/26 8:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock

    DALLAS, July 15, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI", the "Company" or "we") today announced that ASPI and Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, have entered into separate, individually negotiated private exchange agreements (the "Exchange Agreements") with certain holders of QLE’s outstanding convertible promissory notes (the "QLE Notes"). Under the terms of the Exchange Agreements, certain holders of QLE Notes have agreed to exchange approximately $109.2 million in aggregate principal amount of out

    7/15/26 5:58:09 PM ET
    $ASPI
    Major Chemicals
    Industrials

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Gregg bought $999,999 worth of shares (793,650 units at $1.26) (SEC Form 4)

    4 - Vivani Medical, Inc. (0001266806) (Issuer)

    7/16/26 9:00:06 AM ET
    $VANI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Williams Gregg bought $1,999,999 worth of shares (1,587,301 units at $1.26) (SEC Form 4)

    4 - Vivani Medical, Inc. (0001266806) (Issuer)

    6/16/26 9:00:22 AM ET
    $VANI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Turmelle Michael C bought $39,900 worth of shares (5,250 units at $7.60), increasing direct ownership by 7% to 83,582 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    6/1/26 4:01:55 PM ET
    $IPWR
    Semiconductors
    Technology

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CFO and General Counsel Patel Sandip I

    4 - AtlasClear Holdings, Inc. (0001963088) (Issuer)

    7/16/26 8:21:33 PM ET
    $ATCH
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Director Carlson Steven J.

    4 - AtlasClear Holdings, Inc. (0001963088) (Issuer)

    7/16/26 8:17:13 PM ET
    $ATCH
    Finance: Consumer Services
    Finance

    Chief Operations Officer Lewis Bryon Matthew disposed of 10,697 units of Citizens, decreasing direct ownership by 50% to 10,781 units (SEC Form 4)

    4 - CITIZENS, INC. (0000024090) (Issuer)

    7/16/26 11:21:16 AM ET
    $CIA
    Life Insurance
    Finance

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    SEC Filings

    View All

    ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    7/21/26 8:05:13 AM ET
    $ASPI
    Major Chemicals
    Industrials

    SEC Form F-3 filed by Brenmiller Energy Ltd

    F-3 - Brenmiller Energy Ltd. (0001901215) (Filer)

    7/20/26 4:06:35 PM ET
    $BNRG
    Building Products
    Industrials

    SEC Form EFFECT filed by Ideal Power Inc.

    EFFECT - Ideal Power Inc. (0001507957) (Filer)

    7/20/26 12:15:16 AM ET
    $IPWR
    Semiconductors
    Technology

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Leadership Updates

    Live Leadership Updates

    View All

    Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

    ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of August Moretti to its board of directors. Concurrent with this appointment, the Company announced the retirement of Dr. Dean Baker from the board. "We are pleased to welcome August Moretti to our board at this transformative stage for Vivani," said Gregg Williams, Chairman of the Board. "His expertise will be instrumental as we advance our lead semaglutide implant, NPM-139, through clinical-stage development and continue to leverage our propriet

    6/26/26 7:30:00 AM ET
    $VANI
    $FDMT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Brenmiller Energy Appoints Nir Brenmiller as Chief Executive Officer to Lead Commercial Growth and Expand BNRG360(TM) Strategy

    Leadership Transition Reflects Company's Focus on Scaling Commercial Deployment and Capitalizing on Expanding Global Demand for Industrial Decarbonization SolutionsRosh Ha'ayin, Israel--(Newsfile Corp. - May 18, 2026) - Brenmiller Energy Ltd. (NASDAQ:BNRG) ("Brenmiller," "Brenmiller Energy" or the "Company"), a provider of integrated power and heat solutions for industrial and utility customers built around its proprietary thermal energy storage ("TES") technology, today announced that on May 14, 2026 its Board of Directors appointed Nir Brenmiller as Chief Executive Officer. Mr. Avi Brenmiller will remain in his role as the Chairman of the Company's Board of Directors. Mr. Nir Brenmiller's

    5/18/26 9:00:00 AM ET
    $BNRG
    Building Products
    Industrials

    Photronics Names Christopher Dayton as Senior Vice President, Finance

    BROOKFIELD, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today announced the appointment of Christopher Dayton as Senior Vice President, Finance, effective May 11, 2026. Mr. Dayton will be based at the company's corporate headquarters in Brookfield, Connecticut and report directly to Photronics' President & Chief Financial Officer, Eric Rivera. In this role, Mr. Dayton will support execution of Photronics' financial plan, ensure financial governance, and enable long-term growth initiatives across the company's global manufacturing operations. He will provide operational leadership across key areas of th

    5/14/26 4:00:00 PM ET
    $PLAB
    Semiconductors
    Technology

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Financials

    Live finance-specific insights

    View All

    Weatherford Announces Second Quarter 2026 Results

    Second quarter revenue of $1,105 million decreased 4% sequentially  Second quarter operating income of $107 million decreased 13% sequentiallySecond quarter net income of $39 million decreased 64% sequentially; net income margin of 3.5%Second quarter adjusted EBITDA* of $223 million, decreased 4% sequentially; adjusted EBITDA margin* of 20.2% decreased 4 basis points sequentiallySecond quarter cash provided by operating activities of $175 million and adjusted free cash flow* of $139 millionShareholder return of $36 million for the quarter, which included dividend payments of $20 million and share repurchases of $16 millionAnnounced the acquisition of NCS Multistage (NASDAQ:NCSM) in a stock-a

    7/21/26 4:30:00 PM ET
    $WFRD
    $NCSM
    Oil and Gas Field Machinery
    Consumer Discretionary
    Oilfield Services/Equipment
    Energy

    Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

    Australian oncology study advances into Cohort 3 as enrollment continuesEntered the third and final dosing cohort of the Australian oncology study, expanded the Hemopurifier intellectual property portfolio, and maintained a focus on managing operating expenses.Conference Call Today at 4:30 p.m. ETSAN DIEGO, June 10, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a clinical-stage medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections for which there is no treatment, today reported financial results for its fiscal year ended March 31, 2026, and provided an update on recent developments.  Key Highlight

    6/10/26 4:15:00 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

    SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal year end March 31, 2026, at 4:15 p.m. ET on Wednesday, June 10, 2026. Management will host a conference call on Wednesday, June 10, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10209612/1042263e8ec. Please note t

    6/2/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $AEMD
    $ASPI
    $ATCH
    $BNRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by AtlasClear Holdings Inc.

    SC 13D/A - AtlasClear Holdings, Inc. (0001963088) (Subject)

    11/14/24 5:00:29 PM ET
    $ATCH
    Finance: Consumer Services
    Finance